Bovine papillomavirus type 1 E2 and E7 proteins down-regulate Toll Like Receptor 4 (TLR4) expression in equine fibroblasts

Virus Research

Volumn 149, Issue 1, 2010, Pages 124-127

  Yuan, Z Q ^a   Bennett, L ^a   Campo, M S ^a   Nasir, L ^a  

^a Faculty of Veterinary Medicine   (United Kingdom)

Author keywords

Bovine papillomavirus; E2; E7; Toll Like Receptor 4

Indexed keywords

PROTEIN E2; PROTEIN E7; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; BOVINE PAPILLOMAVIRUS TYPE 1; CONTROLLED STUDY; DOWN REGULATION; FETUS; FIBROBLAST CULTURE; GENE EXPRESSION REGULATION; GENE SILENCING; HORSE; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; BOVINE PAPILLOMAVIRUS 1; CELLS, CULTURED; DNA-BINDING PROTEINS; DOWN-REGULATION; EQUIDAE; FIBROBLASTS; GENE SILENCING; HOST-PATHOGEN INTERACTIONS; ONCOGENE PROTEINS, VIRAL; RNA, SMALL INTERFERING; TOLL-LIKE RECEPTOR 4; VIRAL PROTEINS;

BOVINE PAPILLOMAVIRUS; BOVINE PAPILLOMAVIRUS TYPE 1; BOVINE PAPILLOMAVIRUS TYPE 2; EQUIDAE;

EID: 77549088606     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2010.01.008     Document Type: Article

References (49)

1. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
2. Amtmann E., Muller H., and Sauer G. Equine connective tissue tumors contain unintegrated bovine papillomavirus DNA. J. Virol. 35 (1980) 962-964
3. Angelos J.A., Marti E., Lazary S., and Carmichael L.E. Characterisation of BPV-like DNA in equine sarcoids. Arch. Virol. 119 (1991) 95-109
4. Apetoh L., Ghiringhelli F., Tesniere A., Obeid M., Ortiz C., Criollo A., Mignot G., Maiuri M.C., Ullrich E., Saulnier P., Yang H., Amigorena S., Ryffel B., Barrat F.J., Saftig P., Levi F., Lidereau R., Nogues C., Mira J.P., Chompret A., Joulin V., Clavel-Chapelon F., Bourhis J., André F., Delaloge S., Tursz T., Kroemer G., and Zitvogel L. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat. Med. 13 (2007) 1050-1059
5. Araibi E.H., Marchetti B., Ashrafi G.H., and Campo M.S. Downregulation of major histocompatibility complex class I in bovine papillomas. J. Gen. Virol. 85 (2004) 2809-2814
6. Araibi E.H., Marchetti B., Dornan E.S., Ashrafi G.H., Dobromylskyj M., Ellis S.A., and Campo M.S. The E5 oncoprotein of BPV-4 does not interfere with the biosynthetic pathway of non-classical MHC class I. Virology 353 (2006) 174-183
7. Ashrafi G.H., Brown D.R., Fife K.H., and Campo M.S. Down-regulation of MHC class I is a property common to papillomavirus E5 proteins. Virus Res. 120 (2006) 208-211
8. Ashrafi G.H., Haghshenas M., Marchetti B., and Campo M.S. E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domain. Int. J. Cancer 19 (2006) 2105-2112
9. Ashrafi G.H., Haghshenas M.R., Marchetti B., O'Brien P.M., and Campo M.S. E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I. Int. J. Cancer 113 (2005) 276-278
10. Bohl J., Hull B., and Vande Pol S.B. Cooperative transformation and coexpression of bovine papillomavirus type 1 E5 and E7 proteins. J. Virol. 75 (2001) 513-521
11. Borzacchiello G., Russo V., Della Salda L., Roperto S., and Roperto F. Expression of platelet derived growth factor beta receptor and bovine Papillomavirus E5 and E7 oncoproteins in equine sarcoid. J. Comp. Path. 139 (2008) 231-237
12. Brandt S., Haralambus R., Shafti-Keramat S., Steinborn R., Stanek C., Kirnbauer R., and Brandt S. A subset of equine sarcoids harbour BPV-1 DNA in a complex with L1 major capsid protein. Virology 375 (2008) 433-441
13. Brostrom H., Fahlbrink E., Dubath M.L., and Lazary S. Association between equine leucocyte antigens (ELA) and equine sarcoid tumors in the population of Swedish halfbreds and some of their families. Vet. Immunol. Immunopathol. 19 (1988) 215-223
14. Campo M.S. Bovine papillomavirus: old system new lessons?. In: Campo M.S. (Ed). Papillomavirus Research-From Natural History to Vaccines and Beyond (2006), Caister Academic Press, Norfolk, UK 373-387
15. Carr E.A., Theon A.P., Madewelll B.R., Hitchcock M.E., Schlegel R., and Schiller J.T. Expression of a transforming gene (E5) of bovine papillomavirus in sarcoids obtained from horses. Am. J. Vet. Res. 62 (2001) 1212-1217
16. Chambers G., Ellsmore V.A., O'Brien P.M., Reid S.W.J., Love S., Campo M.S., and Nasir L. Sequence variants of bovine papillomavirus E5 detected in equine sarcoids. Virus Res. 96 (2003) 141-145
17. Cordano P., Gillan V., Bratlie S., Bouvard V., Banks L., Tommasino M., and Campo M.S. The E6E7 oncoproteins of cutaneous human papillomavirus type 38 interfere with the interferon pathway. Virology 377 (2008) 408-418
18. Gerber H., Dubath M.-L., and Lazary L. Association between predisposition to equine sarcoid and MHC in multiple-case families. In: Powel D.K. (Ed). Equine Infectious Diseases V-Proceedings of the Sixth International Conference. University Press of Kentucky (1988) 272-277
19. Gobeil P.A., Yuan Z., Gault E.A., Morgan I.M., Campo M.S., and Nasir L. Small interfering RNA targeting bovine papillomavirus type 1 E2 induces apoptosis in equine sarcoid transformed fibroblasts. Virus Res. 145 (2009) 162-165
20. Hasan U.A., Bates E., Takeshita F., Biliato A., Accardi R., Bouvard V., Mansour M., Vincent I., Gissmann L., Iftner T., Sideri M., Stubenrauch F., and Tommasino M. TLR9 expression and function is abolished by the cervical cancer associated human papillomavirus type 16. J. Immunol. 178 (2007) 3186-3197
21. Huang B., Zhao J., Li H., He K.L., Chen Y., Chen S.H., Mayer L., Unkeless J.C., and Xiong H. Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res. 65 (2005) 5009-5014
22. Huang B., Zhao J., Unkeless J.C., Feng Z.H., and Xiong H. TLR signaling by tumor and immune cells: a double-edged sword. Oncogene 27 (2008) 218-224
23. Kawai T., and Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int. Immunol. 21 (2009) 317-337
24. Knottenbelt D.C. A suggested clinical classification for the equine sarcoid. Clin. Tech. Eq. Pract. 4 (2005) 278-295
25. Kumar H., Kawai T., and Akira S. Pathogen recognition in the innate immune response. Biochem. J. 420 (2009) 1-16
26. Kurt-Jones E.A., Popova L., Kwinn L., Haynes L.M., Jones L.P., Tripp R.A., Walsh E.E., Freeman M.W., Golenbock D.T., Anderson L.J., and Finberg R.W. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 5 (2000) 398-401
27. Janeway Jr. C.A., and Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 20 (2002) 197-216
28. Lagos D., Vart R.J., Gratrix F., Westrop S.J., Emuss V., Wong P.P., Robey R., Imami N., Bower M., Gotch F., and Boshoff C. Toll-like receptor 4 mediates innate immunity to Kaposi sarcoma herpesvirus. Cell Host Microbe 4 (2008) 470-483
29. Lancaster W.D. Apparent lack of integration of bovine papillomavirus DNA in virus induced equine and bovine tumour cells and virus transformed mouse cells. Virology 108 (1981) 251-255
30. Marchetti B., Ashrafi G.H., Dornan E.S., Araibi E.H., Ellis S.A., and Campo M.S. The E5 protein of BPV-4 interacts with the heavy chain of MHC class I and irreversibly retains the MHC complex in the Golgi apparatus. Oncogene 25 (2006) 2254-2263
31. Marchetti B., Gault E.A., Cortese M.S., Yuan Z.Q., Ellis S.A., Nasir L., and Campo M.S. Bovine papillomavirus type 1 oncoprotein E5 inhibits equine MHC class I and interacts with equine MHC I heavy chain. J. Gen. Virol. 90 (2009) 2865-2870
32. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 6 (2006) 823-835
33. Martens A., De Moor A., and Ducatelle R. PCR detection of bovine papilloma virus DNA in superficial swabs and scrapings from equine sarcoids. Vet. J. 161 (2001) 280-286
34. McPhillips M.G., Ozato K., and McBride A.A. Interaction of bovine papillomavirus E2 protein with Brd4 stabilizes its association with chromatin. J. Virol. 79 (2005) 8920-8932
35. Meredith D., Elser A.H., Wolf B., Soma L.R., Donawick W.J., and Lazary S. Equine leukocyte antigens: relationships with sarcoid tumours and laminitis in two pure breeds. Immunogenetics 23 (1986) 221-225
36. Mohr I.J., Clark R., Sun S., Androphy E.J., MacPherson P., and Botchan M.R. Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator. Science 250 (1990) 1694-1699
37. Nasir L., and Reid S.W.J. Bovine papillomavirus and equine sarcoids. In: Campo M.S. (Ed). Papillomavirus Research-From Natural History to Vaccines and Beyond (2006), Caister Academic Press, Norfolk, UK 389-398
38. Nasir L., Gault E.A., Morgan I.M., Chambers G., Ellsmore V., and Campo M.S. Identification and functional analysis of sequence variants in the long control region and the E2 open reading frame of bovine papillomavirus type 1 isolated from equine sarcoids. Virology 364 (2007) 355-361
39. Nixon C., Chanbers G., Ellsmore V., Campo M.S., Burr P., Argyle D.J., Reid S.W., and Nasir L. Expression of cell cycle associated proteins cyclin A, CDK-2, p27kip1 and p53 in equine sarcoids. Cancer Lett. 221 (2005) 237-245
40. Park J.S., Kim E.J., Kwon H.J., Hwang E.S., Namkoong S.E., and Um S.J. Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis. J. Biol. Chem. 275 (2000) 6764-6769
41. Perea S.E., Massimim P., and Banks L. Human papillomavirus type 16 E7 impairs the activation of the interferon regulatory factor-1. Int. J. Mol. Med. 6 (2000) 661-666
42. Rassa J.C., Meyers J.L., Zhang Y., Kudaravalli R., and Ross S.R. Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 2281-2286
43. Sullins K.E., Roberts S.M., Lavach J.D., and Severin G.A. Equine Sarcoidosis Eq. Pract. 8 (1986) 21-27
44. Tarwid J.N., Fretz P.B., and Clark E.G. Equine sarcoids: a study with emphasis on pathological diagnosis. Comp. Cont. Ed. 7 (1985) 293-300
45. You J., Croyle J.L., Nishimura A., Ozato K., and Howley P.M. Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell 117 (2004) 349-360
46. Yuan Z.Q., Gallagher A., Gault E.A., Campo M.S., and Nasir L. Bovine papillomavirus infection in equine sarcoids and in bovine bladder cancers. Vet. J. 174 (2007) 599-604
47. Yuan Z.Q., Gault E.A., Gobeil P., Nixon C., Campo M.S., and Nasir L. Establishment and characterization of equine fibroblast cell lines transformed in vivo and in vitro by BPV-1: model systems for equine sarcoids. Virology 373 (2008) 352-361
48. Yuan Z.Q., Nicolson L., Marchetti B., Gault E.A., Campo M.S., and Nasir L. Transcriptional changes induced by bovine papillomavirus type 1 in equine fibroblasts. J. Virol. 82 (2008) 6481-6491
49. Yuan Z.Q., Philbey A.W., Gault E.A., Campo M.S., and Nasir L. Detection of bovine papillomavirus type 1 genomes and viral gene expression in equine inflammatory skin conditions. Virus Res. 124 (2007) 245-249